Literature DB >> 15009536

Cyclosporin A prodrugs: design, synthesis and biophysical properties.

A R Hamel1, F Hubler, A Carrupt, R M Wenger, M Mutter.   

Abstract

The cyclic undecapeptide cyclosporin A (CsA) has a remarkable spectrum of diverse biological activities, including anti-inflammatory, antifungal, antiparasitic as well as immunosuppressive activities. However, the low water solubility of this drug is a serious problem causing undesirable pharmacological properties such as erratic oral absorption. In order to overcome this problem, the design and synthesis of water-soluble prodrugs of CsA are described. Using the OH-MeBmt-1-group as attachment site, we investigate dipeptide systems exhibiting differential tendencies for intramolecular cyclization [diketopiperazine (DKP) formation] for tailoring the chemoreversible release of the parent CsA. In modulating the chemical and structural features of the dipeptide esters (N-alkylation, side chains, C-terminal Pro), we find conversion rates at physiological conditions ranging from minutes to several days. Together with their thermodynamic stability in the solid state and strongly enhanced solubility in water, these chemoreversible CsA prodrugs represent versatile candidates for therapeutical use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009536     DOI: 10.1111/j.1399-3011.2003.00111.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  6 in total

Review 1.  Cyclization-activated prodrugs.

Authors:  Paula Gomes; Nuno Vale; Rui Moreira
Journal:  Molecules       Date:  2007-11-12       Impact factor: 4.411

Review 2.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

3.  New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment.

Authors:  Amandine Gendron; Natalie Lan Linh Tran; Julie Laloy; Romain Brusini; Aurélie Rachet; Frédéric Gobeaux; Valérie Nicolas; Pierre Chaminade; Sonia Abreu; Didier Desmaële; Mariana Varna
Journal:  Pharmaceutics       Date:  2021-01-12       Impact factor: 6.321

4.  Chitosan Membranes Filled with Cyclosporine A as Possible Devices for Local Administration of Drugs in the Treatment of Breast Cancer.

Authors:  Sonia Trombino; Federica Curcio; Teresa Poerio; Michele Pellegrino; Rossella Russo; Roberta Cassano
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

5.  Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin.

Authors:  Sonia Trombino; Camilla Servidio; Annarita Stella Laganà; Filomena Conforti; Mariangela Marrelli; Roberta Cassano
Journal:  Molecules       Date:  2020-08-02       Impact factor: 4.411

Review 6.  Oral cyclosporine A--the current picture of its liposomal and other delivery systems.

Authors:  Aleksander Czogalla
Journal:  Cell Mol Biol Lett       Date:  2008-11-12       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.